沃森生物(300142.SZ):擬終止並註銷珠海橫琴沃森投資基金
格隆匯 3 月 26日丨沃森生物(300142.SZ)公佈,公司於2021年3月24日召開第四屆董事會第二十一次會議和第四屆監事會第十五次會議,審議通過了《關於終止並註銷珠海橫琴沃森投資基金合夥企業(有限合夥)暨關聯交易的議案》。
基金成立後,管理人圍繞合夥企業未來發展戰略對基金投資方向進行了溝通和研討,針對擬投資領域進行了分析,但由於受宏觀形勢和市場環境的變化影響,特別是國家《疫苗管理法》等法律頒佈實施後,基金目前實質上已無法在原定的規劃下進行運作,合夥企業約定的合夥目的已無法實現。為有效控制對外投資風險,提高資金使用效率,保障投資者的利益,經基金普通合夥人和全體有限合夥人謹慎研究,擬終止並註銷該基金,啟動基金清算、分配、註銷程序,向全體合夥人進行資產分配,資產分配完畢後提前終止《珠海橫琴沃森投資基金合夥企業(有限合夥)有限合夥協議》。
終止並註銷該基金,啟動基金清算、分配、註銷程序,公司將全額收回投資。此次終止並註銷基金事項不會對公司的日常生產經營活動產生實質性影響,不會對公司財務狀況和經營狀況產生不利影響,不存在損害公司和股東特別是中小股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.